Addicted to wonder drugs

Number 33

1 November 2009 0

When stories exaggerate the implications of the latest research, is this the fault of the media? Asession on reporting cancer breakthroughs found pressure also comes from researchers and pharmaceutical companies. Maybe the greatest pressure comes [more]

Balancing safety against need

When Pfizer followed Merck & co in withdrawing one of their COX-2 inhibitors from the market owing to increased risks of cardiovascular complications, it provided a timely reminder that medicines are not without their risks. [more]

Brainwaves in drug delivery

Number 5

1 March 2005 0

Delivering drugs through the blood-brain barrier has always confounded scientists, but new developments in both non-invasive targeted brain delivery and brain-implanted drug formulations may provide a way forward. Download full article

UA-77507851-1